LU92902I2 - Gardasil-9/nom du produit: protéine hpv 45 l1 - Google Patents

Gardasil-9/nom du produit: protéine hpv 45 l1 Download PDF

Info

Publication number: LU92902I2
Authority: LU; Luxembourg
Prior art keywords: gardasil; product name; protein hpv; hpv; protein
Prior art date: 2003-09-29

Application number

LU92902C

Other languages

English (en)

French (fr)

Original Assignee

Merck Sharp & Dohme

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-09-29

Filing date

2015-12-08

Publication date

2016-03-08

2015-12-08 Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme

2016-03-08 Publication of LU92902I2 publication Critical patent/LU92902I2/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/01—DNA viruses
- C07K14/025—Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20023—Virus like particles [VLP]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Genetics & Genomics (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Virology (AREA)
Bioinformatics & Cheminformatics (AREA)
Biochemistry (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
Biophysics (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Gastroenterology & Hepatology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Microbiology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Reproductive Health (AREA)
Endocrinology (AREA)
Physics & Mathematics (AREA)
Plant Pathology (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)

LU92902C 2003-09-29 2015-12-08 Gardasil-9/nom du produit: protéine hpv 45 l1 LU92902I2 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US50681203P	2003-09-29	2003-09-29
PCT/US2004/031326 WO2005032586A1 (en)	2003-09-29	2004-09-24	Optimized expression of hpv 45 l1 in yeast

Publications (1)

Publication Number	Publication Date
LU92902I2 true LU92902I2 (fr)	2016-03-08

Family

ID=34421558

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
LU92902C LU92902I2 (fr)	2003-09-29	2015-12-08	Gardasil-9/nom du produit: protéine hpv 45 l1

Country Status (33)

Country	Link
US (2)	US7250170B2 (ru)
EP (1)	EP1673106B1 (ru)
JP (4)	JP5451960B2 (ru)
KR (1)	KR101165278B1 (ru)
CN (1)	CN1859923B (ru)
AR (2)	AR045804A1 (ru)
AT (1)	ATE435029T1 (ru)
AU (1)	AU2004277934B2 (ru)
BE (1)	BE2015C072I2 (ru)
BR (1)	BRPI0414845B8 (ru)
CA (1)	CA2539168C (ru)
CY (2)	CY1110525T1 (ru)
DE (1)	DE602004021828D1 (ru)
DK (1)	DK1673106T3 (ru)
ES (1)	ES2327530T3 (ru)
FR (1)	FR15C0083I2 (ru)
HU (1)	HUS1500063I1 (ru)
IL (1)	IL174458A (ru)
IS (1)	IS2694B (ru)
LT (2)	LTC1673106I2 (ru)
LU (1)	LU92902I2 (ru)
MX (1)	MXPA06003457A (ru)
MY (1)	MY140664A (ru)
NL (1)	NL300776I2 (ru)
NO (3)	NO339932B1 (ru)
NZ (1)	NZ545834A (ru)
PL (1)	PL1673106T3 (ru)
PT (1)	PT1673106E (ru)
RU (1)	RU2360001C2 (ru)
SI (1)	SI1673106T1 (ru)
TW (1)	TWI350853B (ru)
WO (1)	WO2005032586A1 (ru)
ZA (1)	ZA200601961B (ru)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0206360D0 (en)	2002-03-18	2002-05-01	Glaxosmithkline Biolog Sa	Viral antigens
US7858098B2 (en) *	2002-12-20	2010-12-28	Glaxosmithkline Biologicals, S.A.	Vaccine
MY139500A (en)	2003-11-12	2009-10-30	Merck Sharp & Dohme	Optimized expression of hpv 58 l1 in yeast
AU2005230907C1 (en)	2004-03-24	2016-07-28	Merck Sharp & Dohme Llc	Optimized expression of HPV 52 L1 in yeast
US7758866B2 (en)	2004-06-16	2010-07-20	Glaxosmithkline Biologicals, S.A.	Vaccine against HPV16 and HPV18 and at least another HPV type selected from HPV 31, 45 or 52
AU2006236905B2 (en)	2005-04-15	2010-06-03	The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services	Methods and compositions for producing an enhanced immune response to a human papillomavirus immunogen
EA013326B1 (ru) *	2005-04-26	2010-04-30	Глаксосмитклайн Байолоджикалс С.А.	Вакцина
EP2059262B1 (en) *	2006-08-28	2013-08-21	Sungkyunkwan University Foundation for Corporate Collaboration	A dna vaccine for treating or preventing cervical cancer comprising a gene encoding hpv protein
US7709010B2 (en) *	2007-03-09	2010-05-04	Merck Sharp & Dohme Corp.	Papillomavirus vaccine compositions
RU2494106C2 (ru) *	2007-11-23	2013-09-27	Шанхай Зеран Биотекнолоджи Ко., Лтд.	Гены, кодирующие главный капсидный белок l1 вируса папилломы человека, и их применение
JP5758385B2 (ja)	2009-06-19	2015-08-05	アイジェンインコーポレーテッド	子宮頸がんワクチン
CA2799205A1 (en)	2010-05-25	2011-12-01	Qiagen Gaithersburg, Inc.	Fast results hybrid capture assay and associated strategically-truncated probes
AU2012270418B2 (en) *	2011-06-15	2015-08-13	Posvax Co., Ltd	Method for enhancing the production yield of human papillomavirus L1 protein
US20140127260A1 (en)	2011-06-24	2014-05-08	Ramesh V. Chintala	Hpv vaccine formulations comprising aluminum adjuvant and methods of producing same
CN103215302B (zh) *	2012-01-21	2019-01-15	北京安百胜生物科技有限公司	用汉逊酵母表达系统产生hpv18 l1蛋白的方法
CN108624614A (zh) *	2012-03-28	2018-10-09	北京安百胜生物科技有限公司	用汉逊酵母表达系统产生hpv11 l1蛋白的方法
CN104120089B (zh) *	2013-04-26	2019-09-24	北京安百胜生物科技有限公司	用汉逊酵母表达系统产生hpv52 l1蛋白的方法
CN110423774A (zh) *	2013-04-26	2019-11-08	北京安百胜生物科技有限公司	用汉逊酵母表达系统产生hpv58 l1蛋白的方法
CN110295190A (zh) *	2013-05-17	2019-10-01	北京安百胜生物科技有限公司	用汉逊酵母表达系统产生hpv45 l1蛋白的方法
CN112280793B (zh) *	2013-09-29	2022-06-24	上海泽润生物科技有限公司	人乳头瘤病毒基因，及载体，菌株，表达方法
WO2015057541A1 (en)	2013-10-16	2015-04-23	Merck Sharp & Dohme Corp.	Method of obtaining thermostable dried vaccine formulations
WO2016038625A2 (en) *	2014-09-11	2016-03-17	Cadila Healthcare Limited	Superior human papilloma virus antigens with superior immunological properties and vaccine containing it
CN106282278B (zh) *	2015-06-29	2021-06-08	广东东阳光药业有限公司	一种人乳头瘤病毒l1蛋白的发酵方法
CN106701798B (zh) *	2015-08-12	2021-09-17	北京康乐卫士生物技术股份有限公司	45型重组人乳头瘤病毒病毒样颗粒及其制备方法
CN109750050B (zh) *	2017-11-07	2023-08-18	上海泽润生物科技有限公司	重组人乳头瘤病毒45亚型蛋白表达
BR112022015313A2 (pt)	2020-02-14	2022-09-27	Merck Sharp & Dohme Llc	Vacina de hpv
CN112680462B (zh) *	2020-12-29	2022-02-22	上海博唯生物科技有限公司	一种人乳头瘤病毒35型/hpv35型l1/l2及其制备与应用
CN113073105B (zh) *	2021-03-23	2023-06-13	重庆博唯佰泰生物制药有限公司	一种表达hpv 56l1的多核苷酸序列及其表达载体、宿主细胞和应用
EP4380615A1 (en)	2021-08-06	2024-06-12	Merck Sharp & Dohme LLC	Hpv vaccine
WO2023023152A1 (en)	2021-08-19	2023-02-23	Merck Sharp & Dohme Llc	Thermostable lipid nanoparticle and methods of use thereof
TW202513091A (zh)	2023-06-09	2025-04-01	美商默沙東有限責任公司	用於人類乳突病毒疫苗之奈米乳液佐劑組合物

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1995031532A1 (en) *	1994-05-16	1995-11-23	Merck & Co., Inc.	Papillomavirus vaccines
AR004464A1 (es) *	1994-11-14	1998-12-16	Merck Sharp & Dohme	Un metodo para producir una proteina de capside de papilomavirus
IL117459A (en) *	1995-03-22	2005-11-20	Merck & Co Inc	Dna encoding human papillomavirus type 18
IL117591A0 (en) *	1995-03-30	1996-07-23	Merck & Co Inc	Synthetic DNA encoding human papillomavirus type 11 L1 protein
JP2001512308A (ja)	1997-02-07	2001-08-21	メルクエンドカンパニーインコーポレーテッド	合成ｈｉｖｇａｇ遺伝子
JP3366339B2 (ja) *	1997-05-27	2003-01-14	ハニルシンセティックファイバーカンパニーリミテッド	高効率発現ベクターを用いてサッカロミセスセレビジエから再組合蛋白質を製造する方法
JP4434479B2 (ja)	1997-07-09	2010-03-17	ザ・ユニバーシティ・オブ・クイーンズランド	標的の細胞および組織においてタンパク質を選択的に発現するための核酸配列および方法
DE69933875T2 (de) *	1998-08-14	2007-05-31	Merck & Co., Inc.	Protein-verabreichungssystem, das dem menschlichen papillomavirus ähnliche partikel benützt.
SI1105466T1 (sl) *	1998-08-14	2006-08-31	Merck & Co Inc	Postopek za ciscenje virusu podobnih delcev humanega papilomskega virusa
US6991795B1 (en) *	1998-08-14	2006-01-31	Merck & Co., Inc.	Protein delivery system using human papillomavirus virus-like particles
ATE290013T1 (de) *	1998-12-23	2005-03-15	Merck & Co Inc	Neutralsierungs-assay, das humane papillomavirus- ähnliche partikel verwendet
DE60016765T2 (de) *	1999-08-25	2005-11-24	Merck & Co., Inc.	Synthetische papillomavirus gene, welche für expression in menschlichen zellen optimiert sind
US6436402B1 (en) *	1999-10-15	2002-08-20	Merck & Co., Inc.	Process for making human papillomavirus virus-like particles with improved properties
US7026443B1 (en) *	1999-12-10	2006-04-11	Epimmune Inc.	Inducing cellular immune responses to human Papillomavirus using peptide and nucleic acid compositions
JP2004504057A (ja)	2000-07-21	2004-02-12	グラクソ　グループ　リミテッド	コドン最適化されたパピローマウイルス配列
US20040063188A1 (en) *	2002-02-14	2004-04-01	Novavax, Inc.	Kit for treating gastrointestinal tract
GB0206360D0 (en)	2002-03-18	2002-05-01	Glaxosmithkline Biolog Sa	Viral antigens
ATE546529T1 (de)	2003-03-24	2012-03-15	Merck Sharp & Dohme	Optimierte expression von hpv 31 l1 in hefe

2004
- 2004-09-21 MY MYPI20043867A patent/MY140664A/en unknown
- 2004-09-22 AR ARP040103420A patent/AR045804A1/es active IP Right Grant
- 2004-09-23 TW TW093128883A patent/TWI350853B/zh not_active IP Right Cessation
- 2004-09-24 DK DK04788982T patent/DK1673106T3/da active
- 2004-09-24 ES ES04788982T patent/ES2327530T3/es not_active Expired - Lifetime
- 2004-09-24 CA CA2539168A patent/CA2539168C/en not_active Expired - Lifetime
- 2004-09-24 DE DE602004021828T patent/DE602004021828D1/de not_active Expired - Lifetime
- 2004-09-24 PL PL04788982T patent/PL1673106T3/pl unknown
- 2004-09-24 RU RU2006114701/13A patent/RU2360001C2/ru active
- 2004-09-24 AU AU2004277934A patent/AU2004277934B2/en active Active
- 2004-09-24 AT AT04788982T patent/ATE435029T1/de active
- 2004-09-24 EP EP04788982A patent/EP1673106B1/en not_active Expired - Lifetime
- 2004-09-24 NZ NZ545834A patent/NZ545834A/en not_active IP Right Cessation
- 2004-09-24 JP JP2006528190A patent/JP5451960B2/ja not_active Expired - Lifetime
- 2004-09-24 KR KR1020067006044A patent/KR101165278B1/ko not_active Expired - Lifetime
- 2004-09-24 SI SI200431180T patent/SI1673106T1/sl unknown
- 2004-09-24 MX MXPA06003457A patent/MXPA06003457A/es active IP Right Grant
- 2004-09-24 BR BRPI0414845A patent/BRPI0414845B8/pt not_active IP Right Cessation
- 2004-09-24 CN CN2004800281067A patent/CN1859923B/zh not_active Expired - Lifetime
- 2004-09-24 PT PT04788982T patent/PT1673106E/pt unknown
- 2004-09-24 WO PCT/US2004/031326 patent/WO2005032586A1/en not_active Ceased
- 2004-09-24 US US10/573,330 patent/US7250170B2/en not_active Expired - Lifetime
2006
- 2006-03-08 ZA ZA200601961A patent/ZA200601961B/en unknown
- 2006-03-20 IS IS8362A patent/IS2694B/is unknown
- 2006-03-21 IL IL174458A patent/IL174458A/en active IP Right Grant
- 2006-04-28 NO NO20061876A patent/NO339932B1/no active Protection Beyond IP Right Term
2007
- 2007-05-23 US US11/805,453 patent/US7482015B2/en not_active Expired - Lifetime
2009
- 2009-09-21 CY CY20091100973T patent/CY1110525T1/el unknown
2010
- 2010-07-07 AR ARP100102440A patent/AR077396A2/es not_active Application Discontinuation
2011
- 2011-03-02 JP JP2011045589A patent/JP2011152137A/ja active Pending
2014
- 2014-06-24 JP JP2014129350A patent/JP2014221052A/ja active Pending
2015
- 2015-11-30 NL NL300776C patent/NL300776I2/nl unknown
- 2015-12-02 HU HUS1500063C patent/HUS1500063I1/hu unknown
- 2015-12-04 FR FR15C0083C patent/FR15C0083I2/fr active Active
- 2015-12-07 CY CY2015050C patent/CY2015050I1/el unknown
- 2015-12-08 LT LTPA2015049C patent/LTC1673106I2/lt unknown
- 2015-12-08 LT LTPA2015049D patent/LTPA2015049I1/lt unknown
- 2015-12-08 LU LU92902C patent/LU92902I2/xx unknown
- 2015-12-09 BE BE2015C072C patent/BE2015C072I2/nl unknown
2016
- 2016-02-04 JP JP2016019712A patent/JP2016136947A/ja active Pending
2017
- 2017-04-05 NO NO2017012C patent/NO2017012I1/no unknown
2022
- 2022-11-30 NO NO2022051C patent/NO2022051I1/no unknown

Also Published As

Publication number	Publication date
US7482015B2 (en)	2009-01-27
KR101165278B1 (ko)	2012-07-23
WO2005032586A1 (en)	2005-04-14
JP2014221052A (ja)	2014-11-27
IL174458A (en)	2014-06-30
EP1673106A1 (en)	2006-06-28
JP2016136947A (ja)	2016-08-04
AR045804A1 (es)	2005-11-16
ATE435029T1 (de)	2009-07-15
US7250170B2 (en)	2007-07-31
RU2360001C2 (ru)	2009-06-27
AU2004277934B2 (en)	2009-09-17
IS8362A (is)	2006-03-20
CY1110525T1 (el)	2015-04-29
CA2539168A1 (en)	2005-04-14
NL300776I1 (ru)	2015-12-29
PT1673106E (pt)	2009-09-22
FR15C0083I2 (fr)	2016-11-25
NO2022051I1 (no)	2022-11-30
RU2006114701A (ru)	2007-11-10
CN1859923A (zh)	2006-11-08
IL174458A0 (en)	2006-08-01
SI1673106T1 (sl)	2009-12-31
NO339932B1 (no)	2017-02-20
PL1673106T3 (pl)	2009-12-31
TWI350853B (en)	2011-10-21
JP5451960B2 (ja)	2014-03-26
CY2015050I2 (el)	2016-06-22
HUS1500063I1 (hu)	2016-02-29
JP2007507207A (ja)	2007-03-29
NL300776I2 (ru)	2015-12-29
BRPI0414845B8 (pt)	2021-06-15
US20080138361A1 (en)	2008-06-12
BRPI0414845B1 (pt)	2020-10-13
CA2539168C (en)	2011-05-31
KR20070029628A (ko)	2007-03-14
FR15C0083I1 (fr)	2016-08-01
MY140664A (en)	2010-01-15
IS2694B (is)	2010-11-15
DE602004021828D1 (de)	2009-08-13
DK1673106T3 (da)	2009-11-09
ES2327530T3 (es)	2009-10-30
EP1673106B1 (en)	2009-07-01
CY2015050I1 (el)	2016-06-22
US20060240040A1 (en)	2006-10-26
LTC1673106I2 (lt)	2017-05-10
NO20061876L (no)	2006-04-28
BE2015C072I2 (ru)	2023-12-14
AU2004277934A1 (en)	2005-04-14
LTPA2015049I1 (lt)	2016-01-11
JP2011152137A (ja)	2011-08-11
BRPI0414845A (pt)	2006-11-21
NO2017012I1 (no)	2017-04-05
ZA200601961B (en)	2007-05-30
NZ545834A (en)	2009-02-28
CN1859923B (zh)	2012-09-05
TW200521233A (en)	2005-07-01
AR077396A2 (es)	2011-08-24
MXPA06003457A (es)	2006-06-05

Publication	Publication Date	Title
LU92902I2 (fr)	2016-03-08	Gardasil-9/nom du produit: protéine hpv 45 l1
LU92903I2 (fr)	2016-03-08	Gardasil-9/nom du produit:protéine hpv 52 l1
LU92901I2 (fr)	2016-03-08	Gardasil-9/ nom du produit: protéine hpv58l1
FR2838048B1 (fr)	2005-05-27	Produit dentaire reticulable/dereticulable
DE602004012052D1 (de)	2008-04-10	Akustisch gekoppelter Produktaufkleber
DE602004029184D1 (de)	2010-10-28	Einwegscheuerprodukt
ATE555190T1 (de)	2012-05-15	Wegwerfreinigungserzeugnis
FR2819718B1 (fr)	2005-02-25	Produit cosmetique
EP1970753A4 (en)	2009-03-25	IDENTIFICATION MEDIUM
SE0301552L (sv)	2004-11-28	New product
SE0300002L (sv)	2004-07-04	Ny produkt
GB0315248D0 (en)	2003-08-06	HCV regulated protein expression
FR2837844B1 (fr)	2004-09-03	Nouveau produit de renfort
ITMI20031093A1 (it)	2004-11-30	Nuovi prodotti cosmetici policromi
EP1637883A4 (en)	2006-07-19	IMMUNOGROMATOGRAPHIC PROCESS
EP1384767A4 (en)	2006-07-12	LAMINATE
DK1691751T3 (da)	2011-09-26	Hygiejneprodukt
EP1691645A4 (en)	2007-08-01	Apparatus for concealing a product
FI20031105L (fi)	2005-01-29	Hygieniaväline
FR2850973B1 (fr)	2007-04-20	Produit bi-composant
FR2856994B1 (fr)	2005-09-09	Ensemble de distribution de produit
FR2828632B1 (fr)	2005-08-19	Produit de viennoiserie
FI5970U1 (fi)	2003-10-20	Tuotepakkaus
UA8093S (uk)	2003-10-15	Етикетка для молочних виробів
SE0300279D0 (sv)	2003-02-04	New product